Naperville, IL -- (SBWIRE) -- 11/02/2012 -- North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery provides key market data on the North America Diabetes Care Devices market – United States and Canada. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
- Countries covered include United States and Canada.
- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the North America Diabetes Care Devices market.
- Key players covered include LifeScan, Inc., Medtronic, Inc., Bayer HealthCare AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Eli Lilly and Company, Animas Corporation, Novo Nordisk A/S, Insulet Corporation, Sanofi and Nipro Corporation.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the North America Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
LifeScan, Inc. Medtronic, Inc. Bayer HealthCare AG F. Hoffmann-La Roche Ltd. Abbott Laboratories Becton, Dickinson and Company Eli Lilly and Company Novo Nordisk A/S Animas Corporation Insulet Corporation Sanofi Nipro Corporation ARKRAY, Inc.
To view table of contents for this market report please visit: